This inventor holds 1 USPTO granted patent. Top assignee: Sciclone Pharmaceuticals, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations by Vincent Chung-Ying Tam
Introduction
Vincent Chung-Ying Tam is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in improving the quality of life for cancer patients undergoing chemotherapy. His innovative approach focuses on reducing the side effects associated with chemotherapy treatments.
Latest Patents
Vincent Tam holds a patent for a method aimed at reducing the severity of chemotherapy side effects in cancer patients. This method involves administering thymosin α in conjunction with chemotherapy agents. As a result of this innovative approach, patients experience a notable increase in their quality of life, making the treatment process more bearable.
Career Highlights
Vincent Tam is currently associated with SciClone Pharmaceuticals, Inc., where he continues to work on advancements in cancer treatment. His dedication to improving patient outcomes is evident in his research and development efforts.
Collaborations
Vincent has collaborated with esteemed colleagues, including Alfred R. Rudolph and Maggie Jie Quan. Their combined expertise contributes to the ongoing advancements in the pharmaceutical field.
Conclusion
Vincent Chung-Ying Tam's innovative methods in cancer treatment exemplify the impact of dedicated research on patient care. His work not only addresses critical medical challenges but also enhances the overall well-being of patients undergoing chemotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile